Advantages of an alternate-day glucocorticoid treatment strategy for the treatment of IgG4-related disease: A preliminary retrospective cohort study

Alternate-day glucocorticoid (GC) therapy is a treatment option that can reduce GC-associated adverse events. We investigated the safety and efficacy of alternate-day GC therapy in patients with immunoglobulin G4-related disease (IgG4-RD). Medical records of patients with IgG4-RD who were followed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Sho, Nakai, Takehiro, Kawaai, Satoshi, Ikeda, Yukihiko, Suda, Masei, Nomura, Atsushi, Tamaki, Hiromichi, Kishimoto, Mitsumasa, Ohde, Sachiko, Okada, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524883/
https://www.ncbi.nlm.nih.gov/pubmed/36181016
http://dx.doi.org/10.1097/MD.0000000000030932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524883/
https://www.ncbi.nlm.nih.gov/pubmed/36181016
http://dx.doi.org/10.1097/MD.0000000000030932

Ejemplares similares